Best for
Beginner investments
Immunodiagnostic Systems Holdings PLC (IDH) is a publicly traded medical devices business based in the UK. It opened the day at 378p after a previous close of 376p. During the day the price has varied from a low of 378p to a high of 378p. The latest price was 378p (25 minute delay). Immunodiagnostic Systems Holdings is listed on the London Stock Exchange (LSE) and employs 276 staff. All prices are listed in pence sterling.
How to buy shares in Immunodiagnostic Systems Holdings
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: IDH in this case.
- Research Immunodiagnostic Systems Holdings shares. The platform should provide the latest information available.
- Buy your Immunodiagnostic Systems Holdings shares. It's that simple.
Best for
0% commission
Best for
Mobile app
Best for
Referral bonus
What's in this guide?
- Can I buy shares in Immunodiagnostic Systems Holdings?
- Compare share dealing platforms
- Performance over time
- Is Immunodiagnostic Systems Holdings stock a buy or sell?
- Are Immunodiagnostic Systems Holdings shares over-valued?
- Immunodiagnostic Systems Holdings shares summary
- Does Immunodiagnostic Systems Holdings pay a dividend?
- How volatile are Immunodiagnostic Systems Holdings shares?
- Other common questions
Fees for buying 100x Immunodiagnostic Systems Holdings shares with popular platforms
Share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $10 | £0.00 £378.00 total |
Capital at risk |
|
£0 | £250 | £8.00 £386.00 total |
Capital at risk |
|
£0 | No minimum | £0.00 £378.00 total |
Capital at risk |
 |
£0 | £1 | £11.95 £389.95 total |
Capital at risk |
 |
£0 | £0.01 | £1.80 £379.80 total |
Capital at risk |
 |
£9.99 per month | No minimum | £7.99 £385.99 total |
Capital at risk |
 |
£36 per year | £20 | £9.50 £387.50 total |
Capital at risk |
Full comparison of share dealing platforms
Immunodiagnostic Systems Holdings share price (LSE:IDH)
Use our graph to track the performance of IDH stocks over time.Immunodiagnostic Systems Holdings price performance over time
Historical closes compared with the last close of 378p
| 2 years (2020-09-29) | 69.51% |
|---|---|
| 3 years (2019-09-27) | 64.35% |
| 5 years (2017-09-29) | 18.13% |
Is it a good time to buy Immunodiagnostic Systems Holdings stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.
Invest in Immunodiagnostic Systems Holdings shares with IG
- No commission on US shares
- More than 13,000 shares to invest in
- Open your account in minutes
Go to site
Capital at risk
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is Immunodiagnostic Systems Holdings under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.
P/E ratio
Immunodiagnostic Systems Holdings's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 291x. In other words, Immunodiagnostic Systems Holdings shares trade at around 291x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
EBITDA
Immunodiagnostic Systems Holdings's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £3.2 million.
The EBITDA is a measure of a Immunodiagnostic Systems Holdings's overall financial performance and is widely used to measure a its profitability.
Immunodiagnostic Systems Holdings shares at a glance
Information last updated 2021-06-29.
| Open | 378p |
|---|---|
| High | 378p |
| Low | 378p |
| Close | 378p |
| Previous close | 376p |
| Change | 2p |
| Change % | 0.5319% |
Information last updated 2021-08-11.
| 52-week range | 0p - 0p |
|---|---|
| 50-day moving average | 300.4717p |
| 200-day moving average | 248.3138p |
| Wall St. target price | 268.59p |
| PE ratio | 290.7693 |
| Dividend yield | 1.9p (0.5%) |
| Earnings per share (TTM) | 1.3p |
Immunodiagnostic Systems Holdings share dividends
Dividend yield: 0.5% of stock value
Forward annual dividend yield: 0.5% of stock value
Immunodiagnostic Systems Holdings has recently paid out dividends equivalent to 0.50% of its share value annually.
Immunodiagnostic Systems Holdings has paid out, on average, around 158.33% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.5% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 0.5% return on their shares, in the form of dividend payments. In Immunodiagnostic Systems Holdings's case, that would currently equate to about 1.9p per share.
Immunodiagnostic Systems Holdings's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 16 July 2020 (the "ex-dividend date").
Share price volatility
Over the last 12 months, Immunodiagnostic Systems Holdings's shares have ranged in value from as little as 0p up to 0p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Immunodiagnostic Systems Holdings's is 0.9216. This would suggest that Immunodiagnostic Systems Holdings's shares are less volatile than average (for this exchange).
Shares similar to Immunodiagnostic Systems Holdings
Frequently asked questions
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
More guides on Finder
-
How to buy Veru (VERU) shares in the UK
Ever wondered how to buy shares in Veru? We explain how and compare a range of providers that can give you access to many brands, including Veru.
-
How to buy C4 Therapeutics (CCCC) shares in the UK
Ever wondered how to buy shares in C4 Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including C4 Therapeutics.
-
How to buy Clever Leaves (CLVR) shares in the UK
Ever wondered how to buy shares in Clever Leaves? We explain how and compare a range of providers that can give you access to many brands, including Clever Leaves.
-
Mental health stocks: Popular mental health companies to invest in
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
-
Invest in pharmaceutical stocks
Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.
-
How to buy Bone Biologics (BBLG) shares in the UK
Ever wondered how to buy shares in Bone Biologics? We explain how and compare a range of providers that can give you access to many brands, including Bone Biologics.
-
How to buy Adagio Therapeutics (ADGI) shares in the UK
Ever wondered how to buy shares in Adagio Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Adagio.
-
How to buy Bolt Biotherapeutics (BOLT) shares in the UK
Ever wondered how to buy shares in Bolt Biotherapeutics? We explain how and compare a range of providers that can give you access to many brands, including Bolt Biotherapeutics.
-
How to buy Vallon Pharmaceuticals (VLON) shares in the UK
Ever wondered how to buy shares in Vallon Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Vallon Pharmaceuticals.
-
How to buy Qualigen Therapeutics (QLGN) shares in the UK
Ever wondered how to buy shares in Qualigen Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Qualigen.
Ask an Expert